|
| Year of publication | Age | Sex | Country | Site of thrombosis | Admission | GI symptoms on admission | Thrombosis risk factors | Order of occurrence | Comment | Treatment | Outcome |
| Hgb | MCV | Plt |
|
1
[9] | 1987 | 37 | F | UK | Mesenteric vein, PE | n/a | n/a | 654 | Yes | Surgery | Thrombosis first | IgA deficiency + RF | GFD | Improved,
without recurrence |
|
2
[10] | 1994 | 26 | F | Algeria | Hepatic vein | 126 | 85 | 153 | Yes | None | CD first | Noncompliant with GFD | GFD | Lost in follow-up |
|
3
[10] | 1994 | 40 | F | Algeria | Hepatic vein, PVT | 120 | 69 | 450 | Yes | OCP use, MPD | Thrombosis first | Interruption of GFD followed by thrombosis | GFD
Long term Warfarin | Thrombosis reoccurred after stopping GFD despite anticoagulation |
|
4
[11] | 1995 | 46 | F | Algeria | Hepatic vein, PVT | 105 | 107 | 300 | No | MPD | Thrombosis first | Low levels of folic acid and vit B12 | GFD | Improved |
|
5
[7] | 1999 | 35 | M | Australia | DVT, PE | n/a | n/a | n/a | No | Elevated homocysteine level,
MTHFR mutation | Thrombosis first | Low folic acid | GFD
Heparin
Warfarin
Folic acid | n/a
Plan to stop warfarin if homocysteine level normalizes |
|
6
[12] | 2002 | 33 | M | Israel | LV thrombus | 10 | 71 | n/a | Yes | Elevated homocysteine level, low folic acid level | Thrombosis first | Recurrent strokes in the setting of LV thrombus | GFD
Warfarin
Folic acid | Improved |
|
7
[8] | 2003 | 53 | M | Italy | DVT, PE | 108 | n/a | n/a | No | Elevated homocysteine level, low folic acid level | Thrombosis first | Before DVT multiple prior episodes of thrombophlebitis | GFD
Warfarin for 3 months | No recurrence in 1-year follow-up |
|
8
[13] | 2003 | 19 | M | Spain | Hepatic vein | 142 | n/a | 158 | Yes | None | Thrombosis first | Had significant ascites, low folic acid | GFD
Warfarin | No recurrence in 2-year follow-up |
|
9
[14] | 2005 | 33 | F | USA | Central retinal vein | n/a | n/a | n/a | No | Pregnancy
dehydration | CD first | Postpartum | Clopidogrel | n/a |
|
10
[15] | 2006 | 40 | M | UK | Mesenteric veins | n/a | n/a | 481 | Yes | Protein S deficiency | CD first | Coexisting Crohn’s disease | GFD | Improved |
|
11
[16] | 2006 | 30 | F | Saudi Arabia | SMV, PVT, splenic vein thrombosis | 73 | n/a | 518 | No | Elevated homocysteine level | Thrombosis first | Failed iron supplementation | GFD
Heparin
Warfarin | Improved in 6 months’ follow-up |
|
12
[17] | 2008 | 39 | F | India | Splenic vein | 11 | n/a | 170 | No | Elevated homocysteine level | Thrombosis first | n/a | GFD
LMWH | Improved in 6 months’ follow-up |
|
13
[18] | 2009 | 18 | M | Tunisia | DVT | 135 | n/a | 440 | No | Protein S deficiency | Thrombosis first | Significant weight gain with GFD | GFD
Warfarin | Improved, symptom-free 4 years after diagnosis |
|
14
[19] | 2009 | 44 | M | Turkey | DVT | 11.7 | n/a | n/a | Yes | None | CD first | n/a | LMWH
Warfarin | Improvement |
|
15
[20] | 2009 | 19 | M | India | Hepatic vein | 6 | n/a | 175 | No | Protein C and S deficiency | Thrombosis first | N/a | LMWH
Warfarin | Improvement in 10 months’ follow-up |
|
16
[21] | 2010 | 26 | F | UK | Cerebral vein thrombosis | n/a | n/a | n/a | No | None | CD first | Lane Hamilton syndrome | UFH | Improvement |
|
17
[22] | 2012 | 30 | F | Iraq | DVT | 5 | n/a | 950 | No | None | Thrombosis first | n/a | GFD
Warfarin | Improvement |
|
18
[23] | 2016 | 27 | F | Jordan | Hepatic vein | n/a | n/a | 145 | No | None | CD first | Thrombosis occurred despite compliance with GFD | Warfarin
portocaval shunt for ascites | Improved |
|
19
[24] | 2017 | 35 | F | Tunisia | Cerebral vein thrombosis | 9.4 | n/a | n/a | No | OCP use | Thrombosis first | Recurrent cerebral vein thrombosis upon cessation of AC | Warfarin | Improvement |
|
